logo
Share SHARE
FONT-SIZE Plus   Neg

Valeant Pharma To Acquire Certain Assets From Atlantis Pharma - Quick Facts

Valeant Pharmaceuticals International Inc. (VRX,VRX.TO) announced that it has signed an agreement to acquire certain assets from Atlantis Pharma, a branded generics pharmaceutical company located in Mexico with a broad product portfolio, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71 million.

The acquired assets' total revenue in 2011 was approximately $26 million and is expected to deliver double digit growth in 2012. The transaction is expected to close in the second quarter, subject to certain closing conditions including regulatory approvals, and is expected to be immediately accretive.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Cruise itineraries in the Caribbean islands are almost back to business after the hurricanes Irma and Maria blasted through some islands. The Florida-Caribbean Cruise Association announced on a press call Monday that the hardest hit major ports, St. Thomas and St. Croix in the U.S. Virgin Islands, and St. Maarten and San Juan, Puerto Rico, are expected to open by the end of November. Banking major Goldman Sachs Group Inc. (GS) reported Tuesday profit for the third-quarter that declined 3 percent from last year. But, quarterly net revenues increased 2 percent. Both earnings per share and revenues topped analysts' expectations. Weinstein Co. said it has entered into a preliminary agreement for immediate capital infusion from Colony Capital, the global private equity arm of Colony NorthStar, Inc. In addition, Weinstein Co. has entered into a negotiating period with Colony Capital for a potential sale of all or a significant portion of its assets. Further details of the deal were not disclosed.
comments powered by Disqus
Follow RTT